Interactions between health regulation and Health Technology Assessment for coverage in health systems and comprehensive care

被引:0
作者
Ramos, Maira Catharina [1 ,2 ]
Oliveira, Margarete Martins de [1 ]
Andrade, Aurelio Matos de [1 ]
Silva, Erica Tatiane da [1 ]
Elias, Flavia Tavares Silva [1 ]
机构
[1] Fundacao Oswaldo Cruz, Programa Evidencias Polit & Tecnol Saude, Brasilia, DF, Brazil
[2] Ave L3 Norte,S-N,Campus Univ Darcy Ribeiro,Gleba A, BR-70904130 Brasilia, DF, Brazil
来源
SAUDE E SOCIEDADE | 2023年 / 32卷
关键词
Health Technology Assessment; Health Care Coordination and Monitoring; Review; SCIENTIFIC ADVICE; BODIES; REQUIREMENTS; MEDICINES; APPROVAL; SYNERGY;
D O I
10.1590/S0104-12902023220925en
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
This study analyzes the interactions between regulatory and health technology assessment (HTA) processes aimed at health systems coverage. A review was carried out in five databases to identify experiences of articulation between regulatory processes and HTA processes, and 19 publications were selected. Regarding the type of process, early dialogue, scientific advice and parallel advice stood out as forms of interaction between HTA and regulation. The studies addressed the interaction between HTA and health regulation for medicines coverage policies in health systems, with scant evidence in relation to other products. Furthermore, this interaction is basically described according to the entry of new technologies into health systems. The interaction between HTA and health regulation resulted in reduced deadlines for the commercialization and incorporation of the technology into health systems. The types of interaction processes identified can benefit the entire health system, increasing coverage and comprehensiveness of care. However, despite advances, some barriers to interaction between regulatory agencies and the management of coverage systems still persist.
引用
收藏
页数:13
相关论文
共 31 条
  • [1] EARLY DIALOGUE IN EUROPE: PERSPECTIVES ON VALUE, CHALLENGES, AND CONTINUING EVOLUTION
    Balaisyte, Lina
    Joos, Angelika
    Hiligsmann, Mickael
    [J]. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2018, 34 (05) : 514 - 518
  • [2] Health technology assessment and the regulation of medical devices and procedures in Quebec - Synergy, collusion, or collision?
    Battista, RN
    Lance, JM
    Lehoux, P
    Regnier, G
    [J]. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 1999, 15 (03) : 593 - 601
  • [3] Improving the Contribution of Regulatory Assessment Reports to Health Technology Assessments-A Collaboration between the European Medicines Agency and the European network for Health Technology Assessment
    Berntgen, Michael
    Gourvil, Anne
    Pavlovic, Mira
    Goettsch, Wim
    Eichler, Hans-Georg
    Kristensen, Finn Borlum
    [J]. VALUE IN HEALTH, 2014, 17 (05) : 634 - 641
  • [4] Critical Review of European Health-Economic Guidelines for the Health Technology Assessment of Medical Devices
    Blueher, Maximilian
    Saunders, Sita J.
    Mittard, Virginie
    Torres, Rafael Torrejon
    Davis, Jason A.
    Saunders, Rhodri
    [J]. FRONTIERS IN MEDICINE, 2019, 6
  • [5] Proposal for a regulation on health technology assessment in Europe - opinions of policy makers, payers and academics from the field of HTA
    Bonanno, Patricia Vella
    Bucsics, Anna
    Simoens, Steven
    Martin, Antony P.
    Oortwijn, Wija
    Gulbinovic, Jolanta
    Rothe, Celia
    Timoney, Angela
    Ferrario, Alessandra
    Gad, Mohamed
    Salem, Ahmed
    Hoxha, Iris
    Sauermann, Robert
    Kamusheva, Maria
    Dimitrova, Maria
    Petrova, Guenka
    Laius, Ott
    Selke, Gisbert
    Kourafalos, Vasilios
    Yfantopoulos, John
    Magnusson, Einar
    Joppi, Roberta
    Jakupi, Arianit
    Bochenek, Tomasz
    Wladysiuk, Magdalene
    Furtado, Claudia
    Markovic-Pekovic, Vanda
    Mardare, Ileana
    Meshkov, Dmitry
    Furst, Jurij
    Tomek, Dominik
    Cortadellas, Merce Obach
    Zara, Corrine
    Haycox, Alan
    Campbell, Stephen
    Godman, Brian
    [J]. EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2019, 19 (03) : 251 - 261
  • [6] BRASIL, 2018, Diretrizes gerais e guia orientativo para elaboracao de Analise de Impacto Regulatorio-AIR
  • [7] Health technology assessment in universal health coverage
    Chalkidou, Kalipso
    Marten, Robert
    Cutler, Derek
    Culyer, Tony
    Smith, Richard
    Teerawattananon, Yot
    Cluzeau, Francoise
    Li, Ryan
    Sullivan, Richard
    Huang, Yanzhong
    Fan, Victoria
    Glassman, Amanda
    Yu Dezhi
    Gyansa-Lutterodt, Martha
    McPherson, Sam
    Gadelha, Carlos
    Sundararaman, Thiagarajan
    Squires, Neil
    Daulaire, Nils
    Sadanandan, Rajeev
    Shiro, Konuma
    Lemgruber, Alexandre
    [J]. LANCET, 2013, 382 (9910) : E48 - E49
  • [8] Clinical practice guidelines in Brazil - developing a national programme
    Colpani, Veronica
    Kowalski, Sergio Candido
    Stein, Airton Tetelbom
    Buehler, Anna Maria
    Zanetti, Daniel
    Cortes, Gabriel
    de Melo Junior, Edison Vieira
    Ebeidalla, Jorgiany Emerick
    de Oliveira, Natiela Beatriz
    Guerra, Renata Leborato
    Silva, Sarah Nascimento
    Duncan, Bruce B.
    Falavigna, Maicon
    Schunemann, Holger Jens
    [J]. HEALTH RESEARCH POLICY AND SYSTEMS, 2020, 18 (01)
  • [9] How can we optimise health technology assessment and reimbursement decisions to accelerate access to new cardiovascular medicines?
    Cowie, Martin R.
    Bozkurt, Biykem
    Butler, Javed
    Briggs, Andrew
    Kubin, Maria
    Jonas, Adrian
    Adler, Amanda I.
    Patrick-Lake, Bray
    Zannad, Faiez
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2022, 365 : 61 - 68
  • [10] Achieving access: addressing the needs of payors and health technology assessment agencies
    Cox, Jafna L.
    de Pouvourville, Gerard
    [J]. EUROPEAN HEART JOURNAL SUPPLEMENTS, 2015, 17 (0D) : D15 - D20